Please try another search
VIA Pharmaceuticals, Inc. (VIA) is a development-stage biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. The Company’s lead compound, VIA-2291, targets an unmet medical need of reducing atherosclerotic plaque inflammation, which is an underlying cause of atherosclerosis and its complications. Atherosclerosis is a cardiovascular disease that results from chronic inflammation and the build-up of plaque in arterial blood vessel walls. The Company’s clinical development strategy integrates several technologies to provide clinical proof-of-concept, as early as possible in the clinical development process. These technologies include the measurement of biomarkers, medical imaging of the coronary and carotid vessel walls to evaluate the plaque characteristics, and atherosclerotic plaque bioassays.
Name | Age | Since | Title |
---|---|---|---|
Renu Virmani | - | - | Member of Advisory Board |
Jean-Lucien Rouleau | - | - | Member of Clinical Advisory Board |
Donald H. Maurice | - | - | Scientific Advisor |
Garret A. FitzGerald | - | - | Scientific Advisor |
Frederick B. Craves | 76 | 2007 | Director |
Marcelo Di Carli | - | - | Member of Clinical Advisory Board |
Peter Libby | 75 | - | Member of Clinical Advisory Board |
Tod Klingler | 58 | - | Scientific Advisor |
Thomas Quertermous | 70 | 2004 | Chief Scientific Officer & Member of Scientific Advisory Board |
John R. Larson | - | 2003 | Director |
Paul M. Ridker | - | - | Member of Advisory Board |
Christopher Glass | - | - | Scientific Advisor |
David T. Howard | 72 | 2007 | Independent Director |
Marco Conti | - | - | Scientific Advisor |
Robert R. Fenichel | - | - | Member of Clinical Advisory Board |
Israel F. Charo | 72 | - | Scientific Advisor |
Colin Funk | - | - | Scientific Advisor |
Jean Claude Tardif | - | - | Member of Clinical Advisory Board |
Marc Pfeffer | - | - | Chair of Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review